Abstract: Embodiments of the present disclosure are directed towards bicyclic hafnium metallocenes having non-identical ligands and compositions including the bicyclic hafnium metallocenes having non-identical ligands. The bicyclic hafnium metallocene having non-identical ligands is represented by formula (I): ABMX2, where: A is a bicyclic structure; and B is a cyclopentadienyl; M is hafnium; and X is a leaving group, wherein the bicyclic structure comprises a ((C1-C6)alkyl)n-substituted Cp ring and a non-aromatic cyclic structure fused with the ((C1-C6) alkyl)n-substituted Cp ring such that the bicyclic structure includes 7 to 9 ring carbon atoms and wherein subscript n is 1, 2, or 3.

Abstract: Embodiments of the present disclosure are directed towards hafnium metallocenes having nonidentical ligands, spray-dried compositions including those hafnium metallocenes, and methods utilizing spray-dried compositions including hafnium metallocene having nonidentical ligands.

Abstract: Sequences and partial sequences for three types of mammalian (human and rat sequences identified) T-type calcium channel subunits which we have labeled as the ?1G, ?1H and ?1I subunits are provided. Knowledge of the sequence of these calcium channel permits the localization and recovery of the complete sequence from human cells, and the development of cell lines which express the novel calcium channels of the invention. These cells may be used for identifying compounds capable of acting as agonists or antagonists to the calcium channels.

Abstract: Sequences and partial sequences for three types of mammalian (human and rat sequences identified) T-type calcium channel subunits which we have labeled as the ?1G, ?1H and ?1I subunits are provided. Knowledge of the sequence of these calcium channel permits the localization and recovery of the complete sequence from human cells, and the development of cell lines which express the novel calcium channels of the invention. These cells may be used for identifying compounds capable of acting as agonists or antagonists to the calcium channels.